NYSEAMERICAN:CCEL Cryo-Cell International (CCEL) Stock Price, News & Analysis $5.05 -0.30 (-5.61%) Closing price 04:10 PM EasternExtended Trading$5.00 -0.04 (-0.89%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Cryo-Cell International Stock (NYSEAMERICAN:CCEL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CCEL alerts:Sign Up Key Stats Today's Range$5.00▼$5.3550-Day Range$3.53▼$5.3552-Week Range$2.72▼$5.45Volume6,522 shsAverage Volume15,922 shsMarket Capitalization$40.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cryo-Cell International, Inc. is a biotechnology and healthcare services company that provides stem cell collection, processing and long-term cryogenic storage. The company primarily focuses on preserving umbilical cord blood and cord tissue, which contain stem cells that may be used in certain medical treatments and regenerative medicine applications. Its services are marketed primarily to expectant parents and families through private biological material banking programs. Cryo-Cell provides collection kits, coordination with healthcare professionals, laboratory processing and secure storage services. The company has also offered preservation services for menstrual stem cells through its C’elle program. Founded in 1989, Cryo-Cell International is headquartered in Oldsmar, Florida. The company serves customers in the United States and has pursued international business through strategic relationships, affiliates and distribution arrangements. Its operations are centered on maintaining laboratory and storage capabilities for biological specimens over extended periods.AI Generated. May Contain Errors. Read More Receive CCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CCEL Stock News HeadlinesGoodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into MondayOctober 12, 2026 | benzinga.comCryo-Cell International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2026October 10, 2026 | marketscreener.comM$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.November 3 at 1:00 AM | Profits Run (Ad)Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial ResultsOctober 9, 2026 | businesswire.comDer aktuelle Kurs der CryoCell International Inc Aktie beträgt 3,5700.August 6, 2026 | de.investing.comCord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial ResultsJuly 15, 2026 | businesswire.comCryo-Cell Receives Acceptance of Compliance Plan From NYSE AmericanMay 8, 2026 | businesswire.comCryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood BanksApril 28, 2026 | finance.yahoo.comSee More Headlines CCEL Stock Analysis - Frequently Asked Questions How have CCEL shares performed this year? Cryo-Cell International's stock was trading at $3.44 at the start of the year. Since then, CCEL shares have increased by 46.8% and is now trading at $5.05. How were Cryo-Cell International's earnings last quarter? Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) announced its earnings results on Friday, October, 9th. The company reported $0.16 earnings per share (EPS) for the quarter. The business had revenue of $7.82 million for the quarter. How do I buy shares of Cryo-Cell International? Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cryo-Cell International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Advanced Micro Devices (AMD), Walt Disney (DIS), GE Aerospace (GE), Jumia Technologies (JMIA), Netflix (NFLX), NVIDIA (NVDA) and Vertex Pharmaceuticals (VRTX). Company Calendar Last Earnings10/09/2026Today11/03/2026Fiscal Year End11/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CCEL's financial health is in the Green zone, according to TradeSmith. CCEL has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSEAMERICAN:CCEL CIK862692 Webwww.cryo-cell.com Phone(813) 749-2104Fax813-855-4745Employees76Year Founded1989Profitability EPS (Trailing Twelve Months)($1.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$2.43 million Net Margins-6.25% Pretax Margin-6.13% Return on EquityN/A Return on Assets-3.17% Debt Debt-to-Equity RatioN/A Current Ratio0.86 Quick Ratio0.82 Sales & Book Value Annual Sales$31.57 million Price / Sales1.29 Cash FlowN/A Price / Cash FlowN/A Book Value($2.03) per share Price / Book-2.49Miscellaneous Outstanding Shares8,060,000Free Float4,843,000Market Cap$40.70 million OptionableNot Optionable Beta0.50 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NYSEAMERICAN:CCEL) was last updated on 11/3/2026 by MarketBeat.com Staff. From Our PartnersI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just sig...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThe 401k Email 70 Million Investors Might DeleteAn email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will...Brownstone Research | SponsoredCigar Lake Flooded Again Uranium Supply Shock RepeatsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryo-Cell International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryo-Cell International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.